Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity
利用 IgE 类工程抗体对抗恶性肿瘤：通过肿瘤特异性 IgE 抗体对 FcɛRI 介导的嗜碱性粒细胞活化进行初步评估，以评估 I 型超敏反应的风险
期刊:Clinical and Experimental Allergy
影响因子:6.3
doi:10.1111/j.1365-2222.2011.03770.x
S M Rudman, D H Josephs, H Cambrook, P Karagiannis, A E Gilbert, T Dodev, J Hunt, A Koers, A Montes, L Taams, S Canevari, M Figini, P J Blower, A J Beavil, C F Nicodemus, C Corrigan, S B Kaye, F O Nestle, H J Gould, J F Spicer, S N Karagiannis
